Ensysce Biosciences, Inc.

WHO'M
ai
Digital Profiler. Simply click the AI button
CUSIP

293602405
SEDOL

N/A
CIK

0001716947

www.ensysce.com
LEI:
New: Infographics X-Lab
FIGI: -
ENSC

Ensysce Biosciences, Inc.
GICS: - · Sector: Healthcare · Sub-Sector: Biotechnology
AI
PROFILER
NAME
Ensysce Biosciences, Inc.
ISIN
US2936024056
TICKER
ENSC
MIC
XNAS
REUTERS
ENSC.OQ
BLOOMBERG
ENSC US
F&G: 77
6.387,54 S&P · 17,90 Vola-Index · 117.374,11 BTC · 1,17424 EURUSD
FOR INVESTORS
FOR TRADERS
Securities Trading
According to the transactions reported via the short sale register, 3.213 shares of Ensysce Biosciences, Inc. are held by short sellers as of 24.07.2025. The graph shows how the positions have changed in the past. A ranking list and further statistics for US stocks can be found here. You can track the activities of short sellers with a focus on European companies here.
Click here for comprehensive price and chart analyses
smart.AD

Trading Solutions for Professionals

  • 25 kinds of clusters
  • 26 world exchanges
  • 14 different charts
  • 58 necessary for analysis indicators
  • 50+ customized templates for charts


Get your free Demo today

Change of security ID, ticker or Vglb, see link or newswire

At the moment it is not possible to render the historical price development in the form of a chart. There may be various reasons for this, such as a delisting due to a takeover or stock market withdrawal. But don't worry: alternative sources for further research are available to you via the stock exchange symbol, TV icon or the button panel below the chart window. For delistings or ISIN/ticker changes, you may find what you are looking for here.

ENSC
The charts are provided by TradingView. Millions of investors use the innovative tools and solutions. If you are interested in professional tools, e.g. in the field of technical analysis, you are sure to find what you are looking for here.
We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Information on product placements
The information provided in this area is compiled with care and prepared and processed in complex technical process steps. Quality assurance is an integral part of the methods and procedures used. A plausibility check is carried out to the extent that the source data allows. Before further use, especially in the course of any investment decisions, we recommend consulting at least one second independent source for validation.

 

BARRISTA SMART * AD

P R O D U C T   S U G G E S T I O N S